Literature DB >> 6968259

Immunological responses of L. donovani infection in mice and significance of T cell in resistance to experimental leishmaniasis.

H R Rezai, J Farrell, E L Soulsby.   

Abstract

The parasite burdens of livers and spleens of several strains of mice following infection with L. donovani were determined for a period of over 120 days. The parasite loads of the spleens and livers were correlated with the development of immunity to reinfection, footpad sensitivity and antibody titres. The strains of mice studied could be divided into two groups--those highly susceptible and those relatively non-susceptible. The antibody in the susceptible strains appeared 12 days after infection and increased thereafter. The antibody in the less susceptible strains appeared some time later and remained at the same level throughout the test period. In strains CAFl, C57B1/6 and BALB/c skin reactivity to Leishmania antigen developed at the time when the parasite burden had decreased from its peak. Skin reactivity never developed in DBA!l mice, the most highly susceptible strain, and in A/j the least susceptible strain. The development of resistance to reinfection with L. donovani following i.v. and i.p. infection was observed in C57Bl mice. Upon cell transfer from these immune animals, it was found that protective immunity was mediated through the thymus-dependent lymphocytes. Serum from immune mice was not able to confer immunity to the recipient animals.

Entities:  

Mesh:

Year:  1980        PMID: 6968259      PMCID: PMC1538938     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  10 in total

1.  Immunity in kala-azar.

Authors:  P E MANSON-BAHR
Journal:  Trans R Soc Trop Med Hyg       Date:  1961-11       Impact factor: 2.184

2.  Immunological features of kala-azar.

Authors:  H R Rezai; S M Ardehali; G Amirhakimi; A Kharazmi
Journal:  Am J Trop Med Hyg       Date:  1978-11       Impact factor: 2.345

Review 3.  Leishmania.

Authors:  R S Bray
Journal:  Annu Rev Microbiol       Date:  1974       Impact factor: 15.500

4.  Brain-associated theta antigen: reactivity of rabbit anti-mouse brain with mouse lymphoid cells.

Authors:  E S Golub
Journal:  Cell Immunol       Date:  1971-08       Impact factor: 4.868

5.  Genetics of resistance to infection with Salmonella typhimurium in mice.

Authors:  J Plant; A A Glynn
Journal:  J Infect Dis       Date:  1976-01       Impact factor: 5.226

Review 6.  Immunological phenomena in leprosy and related diseases.

Authors:  J L Turk; A D Bryceson
Journal:  Adv Immunol       Date:  1971       Impact factor: 3.543

7.  T lymphocyte-enriched murine peritoneal exudate cells. I. A reliable assay for antigen-induced T lymphocyte proliferation.

Authors:  R H Schwartz; L Jackson; W E Paul
Journal:  J Immunol       Date:  1975-11       Impact factor: 5.422

8.  Application of immunofluorescence to detection of antibody in Leishmania infections.

Authors:  N Behforouz; H R Rezai; S Gettner
Journal:  Ann Trop Med Parasitol       Date:  1976-09

9.  Regulation of Leishmania populations within the host. II. genetic control of acute susceptibility of mice to Leishmania donovani infection.

Authors:  D J Bradley
Journal:  Clin Exp Immunol       Date:  1977-10       Impact factor: 4.330

10.  Regulation of Leishmania populations within the host. I. the variable course of Leishmania donovani infections in mice.

Authors:  D J Bradley; J Kirkley
Journal:  Clin Exp Immunol       Date:  1977-10       Impact factor: 4.330

  10 in total
  9 in total

1.  Photodynamic vaccination of hamsters with inducible suicidal mutants of Leishmania amazonensis elicits immunity against visceral leishmaniasis.

Authors:  Shraddha Kumari; Mukesh Samant; Prashant Khare; Pragya Misra; Sujoy Dutta; Bala Krishna Kolli; Sharad Sharma; Kwang Poo Chang; Anuradha Dube
Journal:  Eur J Immunol       Date:  2009-01       Impact factor: 5.532

2.  Characterization of protective T cells in the acquired response to Leishmania donovani in genetically determined cure (H-2b) and noncure (H-2d) mouse strains.

Authors:  O M Ulczak; E Ghadirian; E Skamene; J M Blackwell; P A Kongshavn
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

3.  Immunoregulation of genetically controlled acquired responses to Leishmania donovani infection in mice: demonstration and characterization of suppressor T cells in noncure mice.

Authors:  J M Blackwell; O M Ulczak
Journal:  Infect Immun       Date:  1984-04       Impact factor: 3.441

4.  Leishmania donovani infection in heterozygous and recombinant H-2 haplotype mice.

Authors:  J M Blackwell
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

5.  Relationship between delayed hypersensitivity response and acquired cell-mediated immunity in C57BL/6J mice infected with Leishmania donovani.

Authors:  J R Fahey; R Herman
Journal:  Infect Immun       Date:  1985-08       Impact factor: 3.441

6.  Induction of delayed-type hypersensitivity to Leishmania major and the concomitant acceleration of disease development in progressive murine cutaneous leishmaniasis.

Authors:  J S Dhaliwal; F Y Liew
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

7.  Visceral spreading depletion of thymus-dependent regions and amyloidosis in mice and hamsters infected intradermally with Leishmania isolated from Sudanese cutaneous leishmaniasis.

Authors:  B Veress; R E Abdalla; A M El Hassan
Journal:  Br J Exp Pathol       Date:  1983-10

8.  Cytotoxicity of human serum for Leishmania donovani amastigotes: antibody facilitation of alternate complement pathway-mediated killing.

Authors:  D L Hoover; M Berger; M H Oppenheim; W T Hockmeyer; M S Meltzer
Journal:  Infect Immun       Date:  1985-01       Impact factor: 3.441

9.  Arginase Is Essential for Survival of Leishmania donovani Promastigotes but Not Intracellular Amastigotes.

Authors:  Jan M Boitz; Caslin A Gilroy; Tamara D Olenyik; Dustin Paradis; Jasmine Perdeh; Kristie Dearman; Madison J Davis; Phillip A Yates; Yuexin Li; Michael K Riscoe; Buddy Ullman; Sigrid C Roberts
Journal:  Infect Immun       Date:  2016-12-29       Impact factor: 3.441

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.